Diffuse large B-cell lymphoma is the most common subtype of non-Hodgkin lymphoma. Tune in as we chat with Dr. Yasmin Karimi from the University of Michigan about the latest breakthroughs in treatment, including combination therapies, CAR T-cell therapy and bispecific antibodies. Discover how these innovations are offering new hope and pathways to cures for patients.

Mentioned on this episode: 

• 
  
• Diffuse large B-cell lymphoma
  
  
• CAR T-cell Therapy
  
  
• Bispecific Antibodies
  
  
• Diffuse Large B-Cell Lymphoma: Effective Practices for Meaningful Care Conversations in a Changing Landscape
  
  
• You and Your Doctor: Actively Participating in Your Care: A Toolkit For Those Living With Or Caring For Someone With Diffuse Large B-Cell Lymphoma (DLBCL)
  

Additional LLS Support Resources: 

• 
  
• Information Specialists 
  
  
• Free Nutrition Consultations
  
  
• Financial support
  
  
• Free telephone/web patient programs 
  
  
• Free booklets 
  
  
• Clinical Trial Support Center
  
  
• Young Adult Resources
  
  
• Online chats 
  
  
• Support groups 
  
  
• Caregiver support 
  
  
• Caregiver Workbook
  
  
• Advocacy and Public Policy
  
  
• Survivorship Workbook
  
  
• LLS Community
  
  
• Mental Health Resources
  

Support for this episode provided by Genmab US, Inc.

The post Emerging Therapies and Hope: Diffuse Large B-cell Lymphoma first appeared on The Bloodline with LLS.